Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
My International Portfolio: Approaching Another Major Milestone And Looking Into Recent Additions
01:16pm, Thursday, 27'th Jul 2023
I'm your main street neighbor investor in his mid-30s sharing his brokerage account investment journey pursuing a dividend growth strategy. Dividends received YTD totaling $4155 up 18% compared to the
Eli Lilly vs. Novo Nordisk: What's the Better Weight-Loss Stock to Buy?
08:15am, Thursday, 27'th Jul 2023
Eli Lilly has a couple of promising weight-loss treatments that could gain approval in the near future. Novo Nordisk's obesity care revenue doubled in the first quarter -- and stands to go still highe
3 Biotech Stocks You Better Be Buying on Each and Every Dip
07:00am, Thursday, 27'th Jul 2023
Biotechnology is one of the most exciting and innovative sectors in the market, offering investors the potential for high returns coupled with groundbreaking discoveries. However, due to regulatory hu
7 ‘Monster' Stocks to Buy Right Now
09:55pm, Wednesday, 26'th Jul 2023
Some of the best-performing stocks, including market monsters helped buoy a rebound in equities. These firms are among the largest corporations in their respective niches and exert significant influe
AI Stocks Lead These 5 Names Near Buy Points
09:17am, Saturday, 22'nd Jul 2023
Artificial intelligence stocks including chipmaker Marvell Technology, Arista Networks and Synopsys, which has launched AI-based chip-design tools, lead this weekend's watch list of five stocks near b
2 Unstoppable Growth Stocks That Could Make You Richer in The Next Decade
08:00am, Saturday, 22'nd Jul 2023
Novo Nordisk and MercadoLibre have both delivered excellent results over the past year. Both companies should massively benefit from important long-term trends ahead.
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
05:05am, Friday, 21'st Jul 2023
Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
3 Healthcare Stocks to Buy as the Market Gets Defensive
12:33am, Tuesday, 18'th Jul 2023
With so much concern about the Federal Reserve and its decision-making implications for forward market trends, investors may do well targeting healthcare stocks. Fundamentally, the underlying sector r
Is Novo Nordisk a Top Dividend Stock?
10:45am, Monday, 17'th Jul 2023
Novo Nordisk stock pays a below-average dividend yield at current levels. Even so, income investors may still want to consider this name for a few solid reasons.
Why Novo Nordisk Stock Flew Higher on Friday
05:07pm, Friday, 14'th Jul 2023
An analyst initiated coverage of the hot pharmaceutical title with a buy recommendation. This followed new indications that demand for Wegovy is surging.
Novo Nordisk says German 4-week Wegovy at highest dose to cost 302 euros
04:24am, Friday, 14'th Jul 2023
Novo Nordisk said on Friday its popular weight-loss drug Wegovy will cost 301.91 euros ($338.35) for four weeks of treatment at the highest dose in Germany, as the Danish drugmaker prepares for a mark
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
01:37pm, Thursday, 13'th Jul 2023
An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.
Novo Nordisk (NVO) Falls on EMA Safety Review of Obesity Drugs
09:34am, Wednesday, 12'th Jul 2023
Novo Nordisk's (NVO) important diabetes care and obesity drugs are under review by the EMA's safety committee for the risk of suicidal behavior with its use. The stock falls 3%.
3 Biotech Stocks That AI is Loving in July
07:51am, Wednesday, 12'th Jul 2023
Artificial intelligence (AI) has become an invaluable tool for investors seeking opportunities in the stock market. Its ability to analyze large amounts of data and recognize patterns makes it an ally
Why Novo Nordisk Stock Sank on Tuesday
04:45pm, Tuesday, 11'th Jul 2023
A media report detailed the lack of staying power of weight loss drugs. Novo Nordisk has gained fame and popularity as the developer of one of those, Wegovy.
